Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Medium-Chain Acyl-Coenzyme A Dehydrogenase Deficiency Molecular Genetics Laboratory London Health Sciences Centre Canada | 1 | 1 |
|
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 185 | 145 |
|
Fatty Acid Oxidation Probe Assay, Fibroblast Culture Mayo Clinic Laboratories Mayo Clinic United States | 7 | 1 |
|
Medium-chain acyl-CoA dehydrogenase deficiency (ACADM gene) Molecular Genetics and Cytogenetics, Clinical Laboratory Service RED DE SALUD UC CHRISTUS Chile | 1 | 1 |
|
Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency, Full Gene Analysis Mayo Clinic Laboratories Mayo Clinic United States | 1 | 1 |
|
Elevated Levels of C6, C8 and C10 Acylcarnitine via the ACADM Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene AG - the Rare Disease Company Germany | 316 | 314 |
|
ACADM - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Carrier Screening Guidelines-Based Panel Ambry Genetics United States | 199 | 164 |
|
Carrier Screening Ashkenazi Jewish Panel Ambry Genetics United States | 51 | 47 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 734 | 744 |
|
Centogene AG - the Rare Disease Company Germany | 669 | 688 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Centogene AG - the Rare Disease Company Germany | 325 | 316 |
|
Centogene AG - the Rare Disease Company Germany | 829 | 848 |
|
Invitae Rhabdomyolysis and Metabolic Myopathy Panel Invitae United States | 202 | 128 |
|
Invitae Nuclear Mitochondrial Disorders Panel Invitae United States | 394 | 319 |
|
Invitae United States | 173 | 119 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.